ChronicLymphocyticLeukemia相关论文
...
Downregulation of circ_0132266 in chronic lymphocytic leukemia promoted cell viability through miR-3
...
Association of insurance status and marital status with outcomes of patients with chronic lymphocyti
...
Transcriptome Sequencing Reveals Alternative Splicing Patterns and an Increased Sensitivity to Splic
...
Identification of Novel Immune-associated Gene Signature for Diagnosis and Survival Prediction in Ch
Objective This study aimed to identify reliable and distinct immune-associated gene signatures for robust classification......
Objective Chronic lymphocytic leukemia(CLL)is one of most common leukemia in the western world,which is characterized by......
...
Chronic lymphocytic leukemia(CLL)remains the most incurable leukemia.Traditional chemotherapeutic treatments,including a......
TP53 Pro72 allele potentially increases the poor prognostic significance of TP53 mutation in chronic
Previous studies have investigated the associations between TP53 mutations and codon 72 polymorphisms and prognosis in c......
A case of Composite Chronic Lymphocyte Leukemia & Lymphoplasmacytic Lymphoma Diagnosed using Flow Cy
Chronic lymphocytic leukemia(CLL)and lymphoplasmacytic lymphoma(LPL)are two distinct“ low grade” mature B-cell neoplas......
...
Presence of serum antinuclear antibodies correlating unfavorable overall survival in patients with c
...
...
Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time t
...
奥妥珠单抗是一种新型人源化抗CD20单抗。多项临床研究显示奥妥珠单抗联合化疗用于初治或复发难治滤泡性淋巴瘤，或用于初治慢性淋巴......
慢性淋巴细胞白血病（ CLL）首次提出疾病中体细胞突变和甲基化改变。这个观点总结了本领域的最新发现和对肿瘤影响。从患者仅有的10％～15......
目的分析氟达拉滨治疗慢性淋巴细胞白血病的临床效果.方法21例慢性淋巴细胞白血病患者分别采用不同的用药方式,对不同年龄、性别、......
目的探讨利妥昔单抗在慢性淋巴细胞白血病(CLL)患者中的疗效。方法回顾性分析本院一线应用氟达拉滨+环磷酰胺±利妥昔单抗方案或环......
